metformin or glp 1 Once-daily oral HRS-7535, a novel nonpeptide GLP-1 receptor agonist (RA), added to led to significant improvements in glycemic control and modest weight reduction in patients with type 2 diabetes (T2D) inadequately GLP-1 drugs beat metformin for

The prescription is typically based on an individuals medical history, weight-loss goals, and specific health needs

This is why a telehealth-first approach can be so beneficial

Summary of dosing guidance 1

8-12 weeks on, 4-6 off

Infections in children with nephrotic syndrome

3 Reduced Food Noise: In our practice, one of the most consistent and profound effects we observe with these treatments is the dampening of food noise. Patients across the board report a significant reduction in the constant mental chatter around foodless overthinking about food choices, fewer cravings, and an overall shift in their relationship with eating